Spyre Therapeutics, Inc.SYRENASDAQ
Loading
Revenue PerformanceStrong
Percentile Rank100
3Y CAGR+238.7%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
+238.7%/yr
vs -12.0%/yr prior
Acceleration
+250.7pp
Accelerating
Percentile
P100
Near historical high
vs 3Y Ago
38.9x
Strong expansion
Streak
1 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$90.49M-
2024$0.00-100.0%
2023$886000.00-62.0%
2022$2.33M-87.6%
2021$18.74M-
2020$0.00-
2019$0.00-100.0%
2018$3.89M-25.3%
2017$5.21M+12.5%
2016$4.63M-